Professor Xiao Yu (Shirley) Wu
Professor, PhD (McMaster)
Dept. of Pharmaceutical Sciences Leslie L. Dan Faculty of Pharmacy Email: [email protected] 
|
Dr. Xiao Yu (Shirley) Wu is a full Professor and elected Fellow of American Association of Pharmaceutical Scientists (AAPS). She was trained in polymer science and engineering and earned her PhD degree in Chemical Engineering with a thesis on polyelectrolytes and stimulus-responsive nanohydrogels. She joined the Faculty of Pharmacy at the University of Toronto in 1994 as a tenure-track faculty member and progressed to Full Professor in 2006.
During her 23 year academic career, Dr. Wu has directed a well-funded innovative research program and become an internationally recognized expert and leader in controlled release dosage forms and novel drug delivery strategies and delivery systems. She is also a dedicated educator who has played a leading role in teaching pharmaceutics and drug delivery in the faculty at both graduate and undergraduate levels over two decades. She has provided excellent multidisciplinary training in pharmaceutics, drug delivery and drug development to ~150 graduate students, undergraduate research students, and postdoctoral researchers working in her laboratory. She has extensive collaborations with scientists in academia and pharmaceutical industry. Dr. Wu has published >150 journal papers and book chapters, and ~270 conference proceedings and abstracts, and delivered >100 invited presentations. She is a co-inventor of 25 issued or pending patents worldwide. Her current research projects include the design and in vitro/in vivo evaluation of blood-brain barrier-penetrating nanoparticles for therapy and imaging of brain cancer and CNS diseases, synergistic drug combination nanomedicine for treatment of multidrug resistant and metastatic breast cancer, hybrid bioreactive nanoparticles for remodeling tumor microenvironment and improving tumor therapy, intelligent polymer and nanotechnology for closed-loop insulin delivery, and computer-aided design of controlled release drug delivery systems. She has received a number of awards including Astra Pharma-AFPC New Investigator Research Award (1999) and AFPC-Pfizer Research Career Award (2016). |
